IMM 3.70% 2.8¢ immutep limited

This chart shows Norvatis is running 2 clinical trials of Lag3...

  1. 7,897 Posts.
    lightbulb Created with Sketch. 114
    This chart shows Norvatis is running 2 clinical trials of Lag3 in Phase 2. We are expecting mile stones payments soon me think ?. Can someone contact the company to verify thanks !

    https://www.hcp.novartis.com/globalassets/commitment-to-lung-cancer.pdf


    - NCT02460224Safety and Efficacy of LAG525 Single Agent and in Combination With PDR001 in Patients With Advanced Malignancies.

    - NCT03365791Phase II Study of PDR001 Plus LAG525 for Patients With Advanced Solid and Hematologic Malignancies.
    Last edited by ML173: 24/04/19
 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
(20min delay)
Last
2.8¢
Change
0.001(3.70%)
Mkt cap ! $108.5M
Open High Low Value Volume
2.8¢ 2.8¢ 2.7¢ $59.07K 2.111M

Buyers (Bids)

No. Vol. Price($)
14 9765842 2.7¢
 

Sellers (Offers)

Price($) Vol. No.
2.8¢ 1365847 3
View Market Depth
Last trade - 15.48pm 18/10/2019 (20 minute delay) ?
(live)
Last
2.7¢
  Change
0.001 ( 0.00 %)
Open High Low Volume
2.8¢ 2.8¢ 2.7¢ 2949843
Last updated 15.51pm 18/10/2019 (live) ?
IMM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.